Annual EBITDA
-$20.44 M
-$6.72 M-48.92%
December 31, 2023
Summary
- As of February 8, 2025, EPRX annual EBITDA is -$20.44 million, with the most recent change of -$6.72 million (-48.92%) on December 31, 2023.
- During the last 3 years, EPRX annual EBITDA has fallen by -$18.94 million (-1261.26%).
- EPRX annual EBITDA is now -1261.26% below its all-time high of -$1.50 million, reached on December 1, 2020.
Performance
EPRX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$5.95 M
-$208.10 K-3.62%
September 1, 2024
Summary
- As of February 8, 2025, EPRX quarterly EBITDA is -$5.95 million, with the most recent change of -$208.10 thousand (-3.62%) on September 1, 2024.
- Over the past year, EPRX quarterly EBITDA has dropped by -$208.10 thousand (-3.62%).
- EPRX quarterly EBITDA is now -3834.69% below its all-time high of $159.40 thousand, reached on December 1, 2020.
Performance
EPRX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$27.76 M
-$1.42 M-5.37%
September 1, 2024
Summary
- As of February 8, 2025, EPRX TTM EBITDA is -$27.76 million, with the most recent change of -$1.42 million (-5.37%) on September 1, 2024.
- Over the past year, EPRX TTM EBITDA has dropped by -$1.42 million (-5.37%).
- EPRX TTM EBITDA is now -2637.61% below its all-time high of -$1.01 million, reached on September 1, 2019.
Performance
EPRX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
EPRX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -48.9% | -3.6% | -5.4% |
| 3 y3 years | -1261.3% | -122.8% | -59.4% |
| 5 y5 years | -81.9% | -445.6% | -1126.5% |
EPRX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -48.9% | at low | -122.8% | +42.0% | -106.0% | +6.7% |
| 5 y | 5-year | -1261.3% | at low | -3834.7% | +42.0% | -2267.6% | +6.7% |
| alltime | all time | -1261.3% | at low | -3834.7% | +42.0% | -2637.6% | +6.7% |
Eupraxia Pharmaceuticals EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$5.95 M(+3.6%) | -$27.76 M(+5.4%) |
| Jun 2024 | - | -$5.75 M(-0.8%) | -$26.35 M(-11.5%) |
| Mar 2024 | - | -$5.79 M(-43.6%) | -$29.77 M(+7.8%) |
| Dec 2023 | -$20.44 M(+48.9%) | -$10.27 M(+126.4%) | -$27.60 M(+8.6%) |
| Sep 2023 | - | -$4.54 M(-50.5%) | -$25.42 M(+3.6%) |
| Jun 2023 | - | -$9.17 M(+152.7%) | -$24.54 M(+23.2%) |
| Mar 2023 | - | -$3.63 M(-55.2%) | -$19.92 M(+4.8%) |
| Dec 2022 | -$13.73 M(-21.6%) | - | - |
| Dec 2022 | - | -$8.09 M(+121.3%) | -$19.00 M(+39.9%) |
| Sep 2022 | - | -$3.65 M(-19.7%) | -$13.59 M(-0.7%) |
| Jun 2022 | - | -$4.55 M(+67.7%) | -$13.68 M(+1.5%) |
| Mar 2022 | - | -$2.71 M(+1.5%) | -$13.48 M(-22.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$17.52 M(+1066.4%) | -$2.67 M(-28.7%) | -$17.41 M(+19.4%) |
| Sep 2021 | - | -$3.75 M(-13.8%) | -$14.58 M(+31.8%) |
| Jun 2021 | - | -$4.35 M(-34.6%) | -$11.07 M(+56.8%) |
| Mar 2021 | - | -$6.65 M(-4269.6%) | -$7.06 M(+369.5%) |
| Dec 2020 | -$1.50 M(-64.2%) | $159.40 K(-168.9%) | -$1.50 M(-17.5%) |
| Sep 2020 | - | -$231.40 K(-32.0%) | -$1.82 M(-30.1%) |
| Jun 2020 | - | -$340.40 K(-68.8%) | -$2.60 M(+15.0%) |
| Mar 2020 | - | -$1.09 M(+588.4%) | -$2.26 M(+93.0%) |
| Dec 2019 | -$4.20 M(-62.6%) | -$158.50 K(-84.4%) | -$1.17 M(+15.6%) |
| Sep 2019 | - | -$1.01 M | -$1.01 M |
| Dec 2018 | -$11.24 M(+199.7%) | - | - |
| Dec 2017 | -$3.75 M | - | - |
FAQ
- What is Eupraxia Pharmaceuticals annual EBITDA?
- What is the all time high annual EBITDA for Eupraxia Pharmaceuticals?
- What is Eupraxia Pharmaceuticals annual EBITDA year-on-year change?
- What is Eupraxia Pharmaceuticals quarterly EBITDA?
- What is the all time high quarterly EBITDA for Eupraxia Pharmaceuticals?
- What is Eupraxia Pharmaceuticals quarterly EBITDA year-on-year change?
- What is Eupraxia Pharmaceuticals TTM EBITDA?
- What is the all time high TTM EBITDA for Eupraxia Pharmaceuticals?
- What is Eupraxia Pharmaceuticals TTM EBITDA year-on-year change?
What is Eupraxia Pharmaceuticals annual EBITDA?
The current annual EBITDA of EPRX is -$20.44 M
What is the all time high annual EBITDA for Eupraxia Pharmaceuticals?
Eupraxia Pharmaceuticals all-time high annual EBITDA is -$1.50 M
What is Eupraxia Pharmaceuticals annual EBITDA year-on-year change?
Over the past year, EPRX annual EBITDA has changed by -$6.72 M (-48.92%)
What is Eupraxia Pharmaceuticals quarterly EBITDA?
The current quarterly EBITDA of EPRX is -$5.95 M
What is the all time high quarterly EBITDA for Eupraxia Pharmaceuticals?
Eupraxia Pharmaceuticals all-time high quarterly EBITDA is $159.40 K
What is Eupraxia Pharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, EPRX quarterly EBITDA has changed by -$208.10 K (-3.62%)
What is Eupraxia Pharmaceuticals TTM EBITDA?
The current TTM EBITDA of EPRX is -$27.76 M
What is the all time high TTM EBITDA for Eupraxia Pharmaceuticals?
Eupraxia Pharmaceuticals all-time high TTM EBITDA is -$1.01 M
What is Eupraxia Pharmaceuticals TTM EBITDA year-on-year change?
Over the past year, EPRX TTM EBITDA has changed by -$1.42 M (-5.37%)